Related Experiment Video
Updated: Sep 14, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
TAF15 mediates ROP16-induced apoptosis and cell cycle arrest in lung cancer
Guangqi Li1,2, Mei Tian3, Yuning Zhou4
1Medical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Objective:
This study aimed to investigate the effects of the interaction between ROP16 and TAF15 on apoptosis and cell cycle regulation in A549 lung adenocarcinoma cells.
Methods:
Lentivirus-infected A549 cells which could overexpress type I, II, and III ROP16, along with an empty vector control group, were established. Potential interacting proteins with ROP16 were identified by using co-immunoprecipitation (Co-IP) and liquid chromatography-mass spectrometry (LC-MS). High-scoring interacting proteins were selected for verification through Venn diagram analysis, scoring, and intensity evaluation. The interaction between ROP16 and TAF15 was confirmed by using co-immunoprecipitation. Moreover, TAF15-specific siRNA was synthesized and transfected into A549 cells overexpressing ROP16 types I, II, and III. The levels of apoptosis and cell cycle were detected by flow cytometry (FCM), and the expression levels of apoptosis-related proteins and cell cycle-related proteins were detected by real-time fluorescence quantitative PCR (RT-qPCR) and western blotting.
Results:
Three stable A549 cell lines overexpressing type I, II, and III ROP16 were successfully established. IP-LC/MS identified 29 potential ROP16-interacting proteins, among which 13 had a score greater than 100. Subsequent bioinformatic analysis and co-immunoprecipitation confirmed the interaction between ROP16 and TAF15. Flow cytometry analysis revealed that type I and III ROP16 promoted A549 cell apoptosis and induced cell cycle arrest. Furthermore, western blotting and RT-qPCR demonstrated their modulation of the expression of cell cycle regulators (p21, CDK6, Cyclin D1) and apoptosis-related proteins (Bax, BCL-2, p53, Caspase-9). In contrast, type II ROP16 exhibited none of these effects. However, upon TAF15 silencing, the pro-apoptotic effects of type I and III ROP16 were attenuated, no significant cell cycle arrest was observed, and their regulatory effects on the expression of cell cycle- and apoptosis-related proteins were also significantly diminished.
Conclusions:
Our study demonstrates that type I/III ROP16 induce apoptosis and cell cycle arrest in A549 cells through interactions with the host RNA-binding protein TAF15. These findings not only provide compelling evidence for the oncosuppressive potential of Toxoplasma gondii-derived secretory proteins but also uncover a previously unrecognized mechanism by which parasite effectors hijack host transcriptional regulators to subvert cancer cell survival pathways.
Insights
Toxoplasma gondii ROP16 (ROP16) protein, specifically types I and III, induces lung adenocarcinoma cell death and cell cycle arrest by interacting with host TAF15. This interaction highlights the oncosuppressive potential of parasite proteins.
Area of Science:
- Molecular biology
- Cancer research
- Parasitology
Background:
- Lung adenocarcinoma is a major cause of cancer mortality.
- Toxoplasma gondii secretory proteins, like ROP16, are investigated for their biological functions.
- Understanding host-pathogen interactions is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the interaction between ROP16 and TAF15 in A549 lung adenocarcinoma cells.
- To determine the effects of this interaction on apoptosis and cell cycle regulation.
- To explore the potential oncosuppressive role of parasite-derived proteins.
Main Methods:
- Established lentivirus-infected A549 cell lines overexpressing ROP16 types I, II, and III.
- Identified ROP16 interacting proteins using co-immunoprecipitation (Co-IP) and liquid chromatography-mass spectrometry (LC-MS).
- Confirmed ROP16-TAF15 interaction and assessed apoptosis and cell cycle changes via flow cytometry, RT-qPCR, and western blotting after TAF15 silencing.
Main Results:
- Confirmed interaction between ROP16 and TAF15.
- Type I and III ROP16 promoted apoptosis and cell cycle arrest in A549 cells, modulating key regulatory proteins.
- Type II ROP16 had no significant effect; TAF15 silencing attenuated the effects of type I/III ROP16.
Conclusions:
- Type I/III ROP16 induce apoptosis and cell cycle arrest in lung adenocarcinoma cells via interaction with TAF15.
- This interaction reveals a mechanism where parasite effectors hijack host transcriptional regulators.
- Toxoplasma gondii-derived secretory proteins exhibit oncosuppressive potential against cancer cell survival.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades

